Medtronic today announced the full U.S. rollout of the Neuroguard IEP system, a carotid stent and embolic protection device. The launch follows a limited market release and builds on Medtronic’s exclusive U.S. distribution agreement with the device’s developer Contego Medical. Neuroguard IEP combines a nitinol stent, dilation balloon and … [Read more...] about Medtronic launches full U.S. distribution of Neuroguard IEP carotid stent system
Business
Jupiter Endovascular raises more than $40M in oversubscribed Series B
Jupiter Endovascular announced today that it closed an oversubscribed Series B financing that surpassed its target of $40 million. Sonder Capital led the financing, while Senvest Management, LB Investment and a new strategic corporate investor participated. Menlo Park, California-plans to use proceeds to complete its ongoing SPIRARE II pivotal … [Read more...] about Jupiter Endovascular raises more than $40M in oversubscribed Series B
Gore, Olympus ink distro deal for Viabil endoprosthesis
Olympus announced today that it entered into a distribution agreement with W.L. Gore & Associates for the Gore Viabil biliary endoprosthesis. The international agreement makes Olympus the exclusive distributor for the Viabil endoprosthesis for endoscopic placement. Olympus plans to begin commercialization over the coming months, beginning in … [Read more...] about Gore, Olympus ink distro deal for Viabil endoprosthesis
Elixir Medical announces full LithiX IVL rollout in Europe
Elixir Medical announced the full market release of its LithiX intravascular lithotripsy (IVL) system in Europe. The Milpitas, California–based company kicked off its initial rollout for the IVL system in Europe following CE mark in April. Now, it has fully launched the advanced hertz contact (HC)-IVL system in the region. Elixir designed LithiX … [Read more...] about Elixir Medical announces full LithiX IVL rollout in Europe
IVL company AVS opens new HQ ahead of commercial launch
Amplitude Vascular Systems (AVS) today announced the opening of its new global headquarters in Waltham, Massachusetts. The new 37,811-square-foot space now serves as the company's hub for innovation, operations and commercialization. It supports the company as it looks to advance its novel Pulse device for pulsatile intravascular lithotripsy … [Read more...] about IVL company AVS opens new HQ ahead of commercial launch
Olympus enters distro deal with MacroLux for single-use urology products
Olympus announced an exclusive global distribution deal with MacroLux Medical Technology to distribute single-use urology products. The agreement includes multiple single-use cytoscopes, ureteroscopes and suction access sheaths. These devices offer access and visualization in the bladder and urinary tract. They enable the diagnosis and treatment … [Read more...] about Olympus enters distro deal with MacroLux for single-use urology products
Penumbra promotes from within to fill president position
Penumbra (NYSE:PEN) announced today that it promoted Shruthi Narayan to the position of president of the company. Narayan's appointment goes into effect on Sept. 1, 2025. She continues to report to Adam Elsesser, who previously held the post of president before this promotion. Elsesser continues on as the Penumbra's chair and CEO. The … [Read more...] about Penumbra promotes from within to fill president position
Pavmed licenses endoscopic esophageal imaging tech out of Duke
Pavmed announced today that it executed a non-binding letter of intent to license endoscopic esophageal imaging technology from Duke University. Through a newly formed subsidiary, Pavmed licensed the technology designed to identify and facilitate treatment of advanced esophageal precancer (dysplasia) during upper endoscopy. It features a … [Read more...] about Pavmed licenses endoscopic esophageal imaging tech out of Duke
ProVerum raises $80M for nitinol stent that treats BPH
ProVerum announced today that it closed an $80 million Series B equity financing to support its device to treat benign prostatic hyperplasia (BPH). MVM Partners led the financing. New investors OrbiMed and the Ireland Strategic Investment Fund (ISIF) also joined in. Existing investors Gilde Healthcare Partners, Lightstone Ventures, Atlantic Bridge … [Read more...] about ProVerum raises $80M for nitinol stent that treats BPH
Second Heart Assist adds investment firm veteran to board
Second Heart Assist announced that it appointed Bill Carpou to its board of directors as it prepares to scale its cardio-renal platform. Carpou currently serves as CEO of Octane, a leading growth platform for medical technology companies. He previously held a senior operating role with Blackstone, the world's largest alternative investment … [Read more...] about Second Heart Assist adds investment firm veteran to board
